News

Chronic hepatitis B treatment relies on nucleoside or nucleotide analogue drugs that suppress hepatitis B virus (HBV) ...
Chronic hepatitis B virus (HBV) is an under-recognised global health threat that affects over 250 million individuals, of whom 80% reside in low-income and middle-income countries (LMICs). HBV causes ...